Data protection Impressum

Healthcare

Geneva's University Hospitals (HUG) are launching a dedicated Women's Cardiovascular Health Center to address the underdiagnosis of heart disease in women.

Geneva’s HUG launches a dedicated cardiovascular health center for women

9 March 2026

On 2 March 2026, Switzerland and the European Union signed a broad package of bilateral agreements in Brussels, establishing a modern framework designed to deepen and expand cooperation across trade, health, energy, research, and market access.

Switzerland and the EU sign a comprehensive bilateral agreement package

3 March 2026

Lausanne-based Xsensio has closed an oversubscribed USD 7 million Series A financing round to accelerate clinical deployment of its Lab-on-Skin wearable biosensing platform, with new backing from WI Harper and a collaboration with Texas Instruments.

Xsensio raises USD 7 million to advance its wearable biosensing platform

3 March 2026

Bracco Imaging, Limula, and the University of Fribourg have launched an Innosuisse-funded research partnership to automate and reduce the cost of CAR-T cell therapy production.

Bracco, Limula and the University of Fribourg join forces to lower the cost of cell therapies

3 March 2026

Geneva-based Clee Medical has raised Seed funding to accelerate clinical validation of its Neuro Access imaging technology for minimally invasive neurosurgery.

Clee Medical secures financing to advance real-time brain imaging platform

25 February 2026

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (February 2026)

25 February 2026

The canton of Vaud seeks CHF 207.6 million to deploy a unified digital patient record across CHUV and regional hospitals.

The canton of Vaud commits over CHF 200 million to next-generation digital patient record

18 February 2026

Scientists at the University of Fribourg have identified a molecular mechanism that keeps certain breast cancer cells dormant by stimulating the immune response, opening new therapeutic perspectives.

Fribourg researchers identify breast cancer dormancy mechanism

11 February 2026

HemostOD has been awarded a CHF 2 million Innosuisse grant to support the preclinical development of its donor-free, off-the-shelf human blood platelets for transfusion.

HemostOD secures CHF 2 million to advance donor-free platelet development

9 February 2026

Swiss start-ups raised CHF 2.9 billion in 2025, marking a strong recovery in venture capital investment led by ICT and biotech.

Swiss start-ups attract CHF 2.9 billion in 2025 as venture capital rebounds

3 February 2026

1 2 3 4 5 6 7 8 9 10 … 24